On the key clinical endpoint, treatment with REGN-
Post# of 148166
(Total Views: 717)
Posted On: 10/28/2020 7:44:20 PM
Quote:
On the key clinical endpoint, treatment with REGN-COV2 reduced COVID-19 related medical visits by 57% through day 29 (2.8% combined dose groups; 6.5% placebo; p=0.024).
Going for an EUA with less than p = .005? Who could have ever imagined that.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼